4.7 Article

Positive Association of Serum Galectin-3 with the Development of Aortic Stiffness of Patients on Peritoneal Dialysis

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Clinical Factors Associated with Arterial Stiffness in Chronic Kidney Disease

Jin Yao et al.

Summary: This study found that in patients with chronic kidney disease (CKD), factors such as female sex, age, smoking, mean arterial pressure (MAP), glomerular filtration rate (eGFR), cause of disease, ACEI/ARB, and glucocorticoid were associated with arterial stiffness.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Peripheral Vascular Disease

Comparing Central Aortic Pressures Obtained Using a SphygmoCor Device to Pressures Obtained Using a Pressure Catheter

Cara Esposito et al.

Summary: This study compared noninvasive estimation of aortic pressures with pressure catheter measurements and analyzed the impact of a linear-fit function. The results showed that the linear-fit function reduced the errors to an acceptable range.

AMERICAN JOURNAL OF HYPERTENSION (2022)

Article Endocrinology & Metabolism

Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot

Yanhua Li et al.

Summary: Galectin-3, a member of the galectin family, plays a crucial role in inflammation, autoimmunity, apoptosis, and chemotaxis, and is widely expressed in immune cells. Clinical research has shown that Galectin-3 levels are closely associated with diabetes and its complications, suggesting its potential use as a predictor and biomarker. Furthermore, Galectin-3 represents a promising therapeutic target for the prevention and treatment of diabetes and its complications, particularly macrovascular and microvascular complications.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2022)

Article Nutrition & Dietetics

A Comparison of SARC-F, Calf Circumference, and Their Combination for Sarcopenia Screening among Patients Undergoing Peritoneal Dialysis

Yu-Li Lin et al.

Summary: This study compared different assessment methods for diagnosing sarcopenia in patients undergoing peritoneal dialysis (PD). The results showed that SARC-CalF and CC performed better than SARC-F in diagnosing sarcopenia. Furthermore, the superiority of SARC-CalF and CC over SARC-F was maintained when stratified by gender.

NUTRIENTS (2022)

Article Biochemistry & Molecular Biology

Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression

Shuo-Ming Ou et al.

Summary: Plasma galectin-3 is associated with organ fibrosis, and this study explored the potential of urinary galectin-3 as a biomarker for kidney disease progression. Patients with higher urinary galectin-3 levels had lower eGFRs and higher proteinuria levels. Higher levels of urinary galectin-3 were also associated with more severe renal fibrosis. The study suggests that urinary galectin-3 levels may be useful for identifying patients at high risk of kidney disease progression and renal fibrosis.

BIOMEDICINES (2022)

Article Peripheral Vascular Disease

Association between circulating Galectin-3 and arterial stiffness in older adults Atherosclerosis Risk in Communities (ARIC) Study

Xiaoming Jia et al.

Summary: This study found that in older adults, gal-3 concentration was associated with central arterial stiffness, likely sharing common pathways with traditional cardiovascular risk factors.

VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2021)

Article Food Science & Technology

Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5

Bang-Gee Hsu et al.

Summary: The study found a significant association between serum galectin-3 and endothelial function in patients with chronic kidney disease, as well as a correlation with CRP levels. Low endothelial function was negatively correlated with high levels of galectin-3 and CRP.

TOXINS (2021)

Review Medicine, General & Internal

Arterial stiffness: A brief review

Jett-Pi Tsai et al.

Summary: AS predicts CVD, especially in CKD patients. The mechanism of AS development involves oxidative stress, inflammation, uremic milieu, etc. There are various non-invasive techniques to measure AS.

TZU CHI MEDICAL JOURNAL (2021)

Article Hematology

Arterial Stiffness Accelerates Within 1 Year of the Final Menstrual Period The SWAN Heart Study

Saad Samargandy et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Review Hematology

Mechanisms of Arterial Stiffening From Mechanotransduction to Epigenetics

Patrick Lacolley et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Review Immunology

Galectin-3 Is a Potential Mediator for Atherosclerosis

Ziyu Gao et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Review Endocrinology & Metabolism

Sex differences in vascular aging in response to testosterone

Kerrie L. Moreau et al.

BIOLOGY OF SEX DIFFERENCES (2020)

Article Cardiac & Cardiovascular Systems

Arterial Stiffness Preceding Diabetes A Longitudinal Study

Mengyi Zheng et al.

CIRCULATION RESEARCH (2020)

Review Biochemistry & Molecular Biology

Galectin-3 in Cardiovascular Diseases

Valeria Blanda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Galectin-3 is associated with arterial stiffness among hemodialysis patients

Qi Zhang et al.

BIOMARKERS IN MEDICINE (2019)

Review Pharmacology & Pharmacy

Sex differences in mechanisms of arterial stiffness

Jennifer J. DuPont et al.

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Article Environmental Sciences

Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway

Hsiu-Chung Ou et al.

ENVIRONMENTAL TOXICOLOGY (2019)

Review Urology & Nephrology

Arterial Stiffness in the Heart Disease of CKD

Luca Zanoli et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Pharmacology & Pharmacy

Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study

Evangelos Oikonomou et al.

CURRENT VASCULAR PHARMACOLOGY (2019)

Article Physiology

Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis

Scott A. Barman et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)

Article Physiology

Aortic-Brachial Stiffness Mismatch and Mortality in Peritoneal Dialysis Patients

WenHan Bao et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2019)

Letter Critical Care Medicine

Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension

Scott A. Barman et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Peripheral Vascular Disease

Arterial Stiffness in Hypertension: an Update

Korshie Dumor et al.

CURRENT HYPERTENSION REPORTS (2018)

Review Transplantation

Large uremic toxins: an unsolved problem in end-stage kidney disease

Martin J. Wolley et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)

Review Medicine, Research & Experimental

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update

Navin Suthahar et al.

THERANOSTICS (2018)

Review Cardiac & Cardiovascular Systems

Galectin-3 in Heart Failure An Update of the Last 3 Years

Carolin Gehlken et al.

HEART FAILURE CLINICS (2018)

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Review Peripheral Vascular Disease

Interaction Between Hypertension and Arterial Stiffness: An Expert Reappraisal

Michel E. Safar et al.

HYPERTENSION (2018)

Review Peripheral Vascular Disease

Large Artery Stiffness Assessment Using SphygmoCor Technology

Mark Butlin et al.

PULSE (2016)

Review Biochemistry & Molecular Biology

The Role of Galectin-3 in the Kidneys

Szu-Chia Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Cardiac & Cardiovascular Systems

Arterial stiffness in diabetes mellitus

Stuart B. Prenner et al.

ATHEROSCLEROSIS (2015)

Article Urology & Nephrology

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

Christiane Drechsler et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Peripheral Vascular Disease

Levels of Serum Phosphorus and Cardiovascular Surrogate Markers

Jinwei Wang et al.

Journal of Atherosclerosis and Thrombosis (2015)

Article Cardiac & Cardiovascular Systems

Galectin-3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis

Julio Madrigal-Matute et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Article Biochemistry & Molecular Biology

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice

Alison C. MacKinnon et al.

GLYCOBIOLOGY (2013)

Article Urology & Nephrology

IMPACT OF ARTERIAL STIFFNESS ON ADVERSE CARDIOVASCULAR OUTCOMES AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS

Murat H. Sipahioglu et al.

PERITONEAL DIALYSIS INTERNATIONAL (2012)

Review Cardiac & Cardiovascular Systems

Aging and Arterial Stiffness

Hae-Young Lee et al.

CIRCULATION JOURNAL (2010)

Article Cardiac & Cardiovascular Systems

Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis

Charalambos Vlachopoulos et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Hematology

Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction

Marianna Papaspyridonos et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)

Review Hematology

Mechanisms, pathophysiology, and therapy of arterial stiffness

SJ Zieman et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)